T1	Participants 164 228	patients with chronic heart failure after myocardial infarction.
T2	Participants 364 397	patients with heart failure (HF).
T3	Participants 560 619	patients with class II to IV HF and ejection fraction <35%.
T4	Participants 770 889	Of 330 patients intended for enrollment, 23 were randomized (MARVEL-1) before stopping the study for financial reasons.
T5	Participants 1424 1481	In HF patients with chronic postinfarction cardiomyopathy
T6	Participants 1789 1838	in HF patients with postinfarction cardiomyopathy
